UBS AM’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-32,165
Closed -$208K 2565
2020
Q1
$208K Buy
32,165
+20,697
+180% +$338K ﹤0.01% 2266
2019
Q4
$235K Buy
11,468
+66
+0.6% +$1.37K ﹤0.01% 2434
2019
Q3
$284K Buy
+11,402
New +$243K ﹤0.01% 2474
2019
Q1
Sell
-70
Closed -$1.42K 2827
2018
Q4
$1.42K Buy
70
+10
+17% +$273 ﹤0.01% 2742
2018
Q3
$2.59K Buy
+60
New +$2.59K ﹤0.01% 2727
2017
Q4
Sell
-3,700
Closed -$212K 2616
2017
Q3
$212K Buy
+3,700
New +$185K ﹤0.01% 2231
2017
Q1
Sell
-3,700
Closed -$229K 2503
2016
Q4
$229K Sell
3,700
-4,900
-57% -$271K ﹤0.01% 2060
2016
Q3
$440K Buy
8,600
+1,400
+19% +$65.6K ﹤0.01% 2049
2016
Q2
$278K Hold
7,200
﹤0.01% 2260
2016
Q1
$234K Hold
7,200
﹤0.01% 2355
2015
Q4
$255K Hold
7,200
﹤0.01% 2418
2015
Q3
$205K Hold
7,200
﹤0.01% 2485
2015
Q2
$213K Buy
7,200
+300
+4% +$8.68K ﹤0.01% 2560
2015
Q1
$219K Buy
+6,900
New +$211K ﹤0.01% 2443

Other funds holding LDL

UBS AM's LDL Position: Q2 2020 in Review

UBS AM sold out of Lydall, Inc. (LDL) in Q2 2020, closing a stake of 32,165 shares — an estimated $208K sold.

UBS AM first reported a position in LDL in Q1 2015 and held it in 14 quarters. The position peaked at $440K in Q3 2016. 133 funds tracked by Wall St. Rank hold LDL as of Q2 2020.

  • UBS AM reported no remaining Lydall, Inc. position as of Q2 2020 after selling out during the quarter.
  • UBS AM sold 32,165 Lydall, Inc. shares in Q2 2020, an estimated $208K.
  • UBS AM first reported a position in Lydall, Inc. in Q1 2015 and held it in 14 quarters.
  • UBS AM's Lydall, Inc. position peaked at $440K in Q3 2016.
  • 133 funds tracked by Wall St. Rank held Lydall, Inc. as of Q2 2020.

Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.